PHC Holdings Corp. (PHCCF)
7.41
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 937.44M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 22.69% |
| Valuation | |
| PE Ratio | 349.53 |
| PE Ratio (Forward) | |
| PS Ratio | 0.3891 |
| Price to Book Value | 0.9225 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.1331 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.451 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. It operates through the following segments: Diabetes Management, Healthcare Solutions, and Diagnosis and Life Science. The Diabetes Management segment deals with the development, manufacture, and sale of in-vitro diagnostic equipment such as self-monitoring blood glucose system, Point of Care Testing products, and electric drug injectors. The Healthcare Solutions segment develops and sells medical IT products such as receipt computers and electronic medical records, and conducts clinical laboratory diagnosis business. The Diagnosis and Life Science segment includes the development, manufacture and sale of research and medical support equipment, and pathological diagnosis equipment. The company was founded in 1969 and is headquartered in Tokyo, Japan. |
| URL | https://www.phchd.com |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 06, 2026 (est.) |
| Last Earnings Release | May. 13, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |
Profile
| PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. It operates through the following segments: Diabetes Management, Healthcare Solutions, and Diagnosis and Life Science. The Diabetes Management segment deals with the development, manufacture, and sale of in-vitro diagnostic equipment such as self-monitoring blood glucose system, Point of Care Testing products, and electric drug injectors. The Healthcare Solutions segment develops and sells medical IT products such as receipt computers and electronic medical records, and conducts clinical laboratory diagnosis business. The Diagnosis and Life Science segment includes the development, manufacture and sale of research and medical support equipment, and pathological diagnosis equipment. The company was founded in 1969 and is headquartered in Tokyo, Japan. |
| URL | https://www.phchd.com |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 06, 2026 (est.) |
| Last Earnings Release | May. 13, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |